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National networks of laboratory-based surveillance of antimicrobial resistance (AMR)
monitor resistance trends and disseminate these data to AMR stakeholders. Whole-genome
sequencing (WGS) can support surveillance by pinpointing resistance mechanisms and
uncovering transmission patterns. However, genomic surveillance is rare in low- and middle-
income countries. Here, we implement WGS within the established Antimicrobial Resistance
Surveillance Program of the Philippines via a binational collaboration. In parallel, we char-
acterize bacterial populations of key bug-drug combinations via a retrospective sequencing
survey. By linking the resistance phenotypes to genomic data, we reveal the interplay of
genetic lineages (strains), AMR mechanisms, and AMR vehicles underlying the expansion of
specific resistance phenotypes that coincide with the growing carbapenem resistance rates
observed since 2010. Our results enhance our understanding of the drivers of carbapenem
resistance in the Philippines, while also serving as the genetic background to contextualize
ongoing local prospective surveillance.
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Antimicrobial resistance (AMR) is an increasingly seriousthreat to global public health and the economy thatrequires concerted action across countries, government
sectors and non-government organizations1. Without AMR
containment, an adverse impact on medical costs, global gross
domestic product, livestock production and international trade is
expected by 2050, and the sustainable development goals for 2030
are less likely to be attained2. The Global Action Plan developed
by the World Health Organization (WHO) to tackle AMR
highlights the need to strengthen our understanding of how
resistance develops and spreads, and the underlying resistance
mechanisms3. One of the pillars of this objective is the national
surveillance system for AMR.
An advanced example of a national surveillance system is the
Antimicrobial Resistance Surveillance Program (ARSP), the
national laboratory-based surveillance of the Philippine Depart-
ment of Health (DOH). The ARSP began in 1988 with eight
hospital-based laboratories (sentinel sites) and the Antimicrobial
Resistance Surveillance Reference Laboratory (ARSRL) in Metro
Manila and has since expanded to 24 sentinel sites and two
gonorrhoea surveillance sites in 16 regions of the country (Sup-
plementary Fig. 1). Surveillance encompasses common pathogens
of public health importance in the Philippines, where infectious
diseases represented nine out of the ten leading causes of mor-
bidity4, and four out of the ten leading causes of infant mortality5
in 2013–2014. Results of culture-based identification and anti-
microbial susceptibility are stored centrally at the ARSRL within
the clinical microbiology management software WHONET
(Fig. 1a6). A report summarizing the resistance trends is pub-
lished annually and disseminated to local, national and interna-
tional surveillance stakeholders7. For policy change, surveillance
data generated by ARSP are used by the DOH to develop clinical
practice guidelines and determine the panel of antibiotics to be
included in the national formulary. Furthermore, the ARSP has
been contributing data to international AMR surveillance pro-
grammes since the 1980s, including the Global Antimicrobial
Surveillance System (GLASS)8 since 2015. Importantly, the ARSP
data has informed the Philippine National Action Plan to combat
AMR, one of the key requirements for alignment with the WHO
Global Action Plan.
The Philippines has seen a steady increase in resistance rates
for several key pathogen–antibiotic combinations in the last 10
years, including carbapenem-resistant organisms (Fig. 1b). The
genetic mechanisms underlying carbapenem resistance, one of the
biggest therapeutic challenges in the treatment of antimicrobial-
resistant infections, include increased upregulation of efflux
pumps, decreased uptake by altered expression/loss of porin
function, and acquisition of hydrolytic enzymes—carbapene-
mases9. Whole-genome sequencing (WGS) of bacterial pathogens
can identify distinct clonal lineages (strains) on phylogenetic
trees, known AMR mechanisms (genes or mutations) and the
vehicles for the acquired AMR genes (mobile genetic elements,
MGEs) which, in turn, enables enhanced detection and char-
acterization of high-risk clones (Fig. 1a). WGS is routinely used
for infectious disease epidemiology in several high-income
countries around the world, where it has improved outbreak
investigations and epidemiological surveillance10,11 and enhanced
our knowledge of the spread of antimicrobial-resistant strains and
their resistance mechanisms12,13. Elucidation of resistance
mechanisms and their context can be critical for effective infec-
tion control. For example, upregulation of efflux pumps and loss
of porin function by mutation are vertically transmitted, while
acquired carbapenemases carried in transmissible plasmids or
integrative conjugative elements have the potential for horizontal
dissemination between strains and species, thus necessitating
enhanced infection control measures14. Moreover, diverse
carbapenemase classes, variants, flanking MGEs and associated
plasmid incompatibility groups have been described, requiring
multiple biochemical and molecular tests for identification. For
example, the class B New Delhi metallo-beta-lactamase (NDM) is
found worldwide, represented by over ten different variants that
are usually upstream of intact or truncated ISAba125 elements,
within plasmid backbones of different incompatibility groups,
across multiple lineages of E. coli—as well as of other
carbapenem-resistant organisms15,16. WGS can determine the
interplay between these different components, i.e. the gene, the
vehicle and the strain, thus maximizing the epidemiological
benefit derived from its cost.
Implementation of WGS within existing national surveillance
systems in low- and middle-income countries (LMICs) has the
potential to enhance local prevention and control of resistant
infections in a sustainable and equitable manner. Integration of
WGS into routine surveillance of AMR can be facilitated by
international collaboration focused on transfer of expertize and
ownership. Our collaboration (See and Sequence, Fig. 1a) aimed
to implement WGS within the ARSP via a multi-faceted approach
that included a large initial retrospective sequencing survey,
technology transfer, utilization of user-friendly web applications
and capacity building in laboratory and bioinformatic procedures
for local prospective sequencing. We linked what has traditionally
been used as the operational unit of laboratory surveillance, the
resistance profile (RP), with the operational unit of genomic
epidemiology now provided by WGS, genetic relatedness. Here
we provide exemplars from the retrospective sequencing survey
that highlight how the granular view of strain-gene-vehicle in
carbapenem-resistant populations at the local, national and global
operational scales can be leveraged for surveillance of AMR and
public health.
Results
Integration of laboratory and genomic surveillance. The Phi-
lippine ARSP collects bacterial isolates and stores the associated
clinical and epidemiological data in the WHONET software6.
Antibiograms are stored as RPs, which represent the diversity of
AMR phenotypes in the country. We implemented WGS within
the ARSP via ongoing technology transfer, capacity building in
and binational collaboration. In parallel, we conducted a large
retrospective sequencing survey to characterize bacterial popula-
tions, dissect resistance phenotypes of key bug–drug combina-
tions and provide genomic context for local prospective
surveillance. Here, we focus on the carbapenem-resistant organ-
isms, which have been classified as of critical priority for the
development of new antibiotics by the WHO.
Operational unit of laboratory surveillance—increasing the
burden of specific resistance phenotypes. Carbapenem-resistant
P. aeruginosa, A. baumannii, K. pneumoniae and E. coli were all
first isolated by the ARSP between 1992 and 1994. Since the year
2000, resistance rates to imipenem and meropenem have
remained below 30% for all organisms except for A. baumannii,
which has seen a steady rise in resistance rates between 2009 and
2017, reaching 56% (Fig. 2a). This coincides with the expansion of
two RPs, first a striking expansion of true extremely drug-
resistant (XDR) and possible pan drug-resistant (PDR) RP-1, and
later of true-XDR RP-2 (full profiles can be found in Fig. 2b).
Yearly resistance rates for P. aeruginosa have oscillated between
10 and 25% since the year 2000, and have doubled between 2010
and 2013 (Fig. 2a). Two RPs have seen the largest combined
expansion between 2011 and 2013, possible-PDR RP-3 and true-
XDR RP-4 (Fig. 2b). The yearly resistance rates to imipenem for
Enterobacteriaceae were ~3% in 2011 but have since steadily
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increased to 5% for E. coli and 11% for K. pneumoniae, respec-
tively (Fig. 2a). This coincides with the expansion of three
possible-XDR RPs, RP-5, RP-6 and RP-7 (Fig. 2b). The observed
expansion of specific RPs could be driven by the rapid dis-
semination of a discrete genetic lineage (strain) carrying AMR
determinants or, alternatively, of transmissible MGEs, which
shuttle resistance determinants across different genetic lineages.
Operational unit of genomic surveillance—genetic diversity
and mechanisms underpinning carbapenem resistance pheno-
types. The sequences of 805 genomes linked to WHONET data
were obtained from isolates belonging to the four bacterial
pathogens in the WHO critical list (Table 1), which were collected
in 2013 and 2014 by between 13 and 18 ARSP sites. The isolates
sequenced were non-susceptible to carbapenems and/or to
extended-spectrum cephalosporins (Table 1), with the exception
of P. aeruginosa, for which susceptible isolates were available and
also sequenced.
The distribution of the carbapenem RPs highlighted in Fig. 2
was not concordant with the major clades observed on the
phylogenetic trees (Fig. 3). Instead, the same RP was usually
observed in multiple genetic lineages across the tree. Yet, the
distribution of the multi-locus sequence types (STs), a molecular
genotyping method inferred from the sequences of seven house-
keeping genes, was largely concordant with the major clades
observed on the trees inferred from whole-genome single-
nucleotide polymorphisms (SNPs) (Fig. 3), confirming that the
homoplasic distribution of RPs was not an artefact of the tree
topology. The distribution of the same carbapenem RPs across
multiple genetic lineages was observed both at the national and
local levels (Supplementary Fig. 2), as the number of ST
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Fig. 1 Implementing whole-genome sequencing (WGS) for AMR surveillance in the Philippines. a ARSP workflow and enhanced detection of high-risk
clones by WGS. Isolates collected by sentinel sites are tested for susceptibility to antibiotics (open squares: susceptible, solid squares: resistant). The data
are stored as resistance profiles in WHONET and summaries of resistance trends are shared yearly with surveillance stakeholders. WGS of bacterial
isolates and interpretation with web applications like Microreact and Pathogenwatch provide information on genetic relatedness (strains), known AMR
determinants (mechanisms), and the mobile genetic elements (MGE, vehicles) for their dissemination, thus allowing us to detect high-risk clones. b Detail
of trends in antimicrobial resistance in the Philippines. Yearly resistance rates for key bug–drug combinations based on phenotypic data collected by
sentinel sites. EBC Enterobacteriaceae (K. pneumoniae, E. coli, Salmonella enterica), PAE P. aeruginosa, ABA A. baumannii (Acinetobacter spp. before the year
2000), SAL Salmonella enterica, SAU S. aureus, ESBL extended-spectrum beta-lactamase production suspected, or non-susceptible to the following
antibiotics IPM imipenem, CIP ciprofloxacin, OXA oxacillin, WGS box: period covered by the retrospective sequencing survey.
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assignments increased with the number of isolates representing a
RP. Thus, the genomic data suggest that the expansion of specific
carbapenem RPs in the Philippines is driven by the horizontal
dissemination of resistance determinants across diverse genetic
backgrounds, rather than by the sole expansion of single resistant
genetic clones, and that resistance to multiple antibiotics is
acquired en bloc via MGEs, as previously observed for
carbapenem-resistant organisms16.
Carbapenemases are a diverse collection of hydrolytic
enzymes16, and we identified representatives of classes A, B and
C carbapenemases in the Philippines (Supplementary Fig. 3).
Class B NDM-1 and Verona integron-borne metallo-beta-
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Fig. 2 Temporal dynamics of carbapenem resistance profiles. a Yearly carbapenem resistance rates (IPM imipenem, MEM meropenem) for A. baumannii,
P. aeruginosa, K. pneumoniae and E. coli. b Relative abundance of carbapenem resistance profiles (non-susceptible to imipenem and/or meropenem). The
three-letter antibiotic codes (as in Table 1) indicate that the isolate is non-susceptible (resistant or intermediate). Only carbapenem non-susceptible
isolates with complete susceptibility data were included, as indicated by the numbers under the x-axis (N). WGS box: period covered by the retrospective
whole-genome sequencing survey.
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lactamase VIM-2 were the most prevalent and geographically
disseminated in the Enterobacteriaceae and P. aeruginosa,
respectively, while the same was true for class D OXA-23 in A.
baumannii. Importantly, different carbapenemase genes/variants
(or combinations thereof) were found underlying the same RP in
all four organisms (Fig. 3).
Local scale of surveillance—plasmid-driven hospital outbreak
of carbapenem-resistant K. pneumoniae. Fifty-seven percent
(N= 33) of the K. pneumoniae genomes with the possible-XDR
resistance phenotype AMP FOX CAZ CRO FEP IPM AMC TZP
GEN AMK CIP SXT (RP-6) were isolated from a single hospital
(MMH) but belonged to 12 different STs, with almost half of
them (N= 15) placed within ST340 (Supplementary Fig. 4a). The
phylogenetic analysis of these 15 genomes in the wider context of
ST340 showed three main lineages, with the 15 possible-XDR
isolates from MMH forming a tight cluster (clade III, Fig. 4a). The
shorter branch lengths in the imipenem-resistant clade III (6.5 ±
3.7 pairwise SNP differences) compared with the imipenem-
susceptible clade II (26.8 ± 6.9 pairwise SNP differences,
Mann–Whitney U test z-score −6.265, p value= 3.71 × 10−10,
Supplementary Fig. 4b), and the isolation dates spanning
12 months, suggest a rapid expansion of this clone, which coin-
cides with the acquisition of the blaNDM-1 gene (Fig. 4a).
Epidemiological data showed that the samples were mostly
from hospital-acquired infections (HAI, N= 14) and from
neonates (N= 12) (Fig. 4a). These observations triggered a
retrospective epidemiological investigation that revealed that ten
of the isolates originated from patients of the neonatal intensive
care unit (NICU), all of which had umbilical catheters and were
on mechanical ventilators. The remaining cases were either from
paediatric wards (N= 4) or the male ward (N= 1), suggesting
wider dissemination of this high-risk clone within the hospital
environment.
The genetic diversity underlying the 33 possible-XDR isolates
from MMH (12 STs) prompted us to investigate the hypothesis of
dissemination of carbapenem resistance in the hospital by a plasmid
carrying blaNDM-1. We identified a 101,540 bp IncFII plasmid with
blaNDM-1, rmtC and sul1 (p13ARS_MMH0112-3, Table 2, Supple-
mentary Note 1 and Supplementary Fig. 5a, b) in a representative
isolate from ST340 clade III. We found the entire
p13ARS_MMH0112-3 plasmid sequence (i.e., ≥95% of the length)
represented in 27 genomes from 9 different STs, including
20 samples from 6 different STs isolated from patients under 1 year
old (Fig. 4b). A second plasmid identified in the representative
isolate carried 13 AMR genes, including the extended-spectrum
beta-lactamase gene blaCTX-M-15 (p13ARS_MMH0112-2, Table 2,
Supplementary Note 2 and Supplementary Fig. 5a, c).
Altogether, our findings suggest that the burden of carbapenem-
resistant K. pneumoniae infections in hospital MMH was largely
linked to plasmid p13ARS_MMH0112-3 with blaNDM-1, circulat-
ing within diverse genetic lineages, and leading to outbreaks in
high-risk patient populations. Hospital authorities were informed
of these findings, and measures for infection control were
implemented, including designating a separate multi-drug resis-
tance organism room for cohorting, active surveillance upon
identification of any new carbapenem-resistant K. pneumoniae
from the NICU, and referral of any new carbapenem-resistant K.
pneumoniae from the NICU to ARSRL for sequencing.
National scale of surveillance—regional circulation of a suc-
cessful K. pneumoniae lineage. The possible-XDR resistance
phenotype AMP FOX CAZ CRO FEP IPM AMC TZP CIP SXT
(RP-5) was represented by 76 K. pneumoniae isolates from 14
different STs. Seventy-one percent (N= 54) belonged to ST147,
an international epidemic clone that was found in 11 sentinel sites
in all three island groups in the Philippines. The phylogeny of the
ST147 genomes showed that carbapenem non-susceptible isolates
(78.8%, N= 63) were found in clades arising from three out of
four deep branches of the tree (Fig. 5), which represent separate
groups of the global population (Supplementary Note 3 and
Supplementary Fig. 6). Carbapenem resistance was largely
explained by the presence of blaNDM-1 in clade IV genomes, while
clade III-B showed geographically distinct clusters with either
blaNDM-1 or blaNDM-7 (Fig. 5, Supplementary Note 4 and Sup-
plementary Fig. 7).
Five plasmid sequences obtained from five different isolates
representing carbapenem-resistant clusters in clades III and IV
showed that the NDM genes were carried within different
variants of the insertion sequence ISAba125 (Supplementary
Fig. 8a) on different plasmid backbones, two of which showed
high sequence similarity to international plasmids (Table 3 and
Supplementary Figs. 5b and 8b). The distribution of plasmids
harbouring blaNDM-1 and blaNDM-7 matched the strong phylogeo-
graphic signal in the terminal branches of the tree (Fig. 5). Within
clade III-B, a cluster of genomes from sentinel sites MMH and
STU was characterized by plasmid p14ARS_MMH0055-5 carry-
ing blaNDM-7, while another cluster of genomes from VSM and
NMC was distinguished by plasmid p13ARS_VSM0593-1 with
blaNDM-1. Plasmids p13ARS_GMH0099 and p14ARS_VSM0843-
1, both carrying blaNDM-1, were found in different subclades of
clade IV, one of local circulation in hospital VSM, and another
one showing regional expansion across five sentinel sites (Fig. 5).
Taken together, the phylogeographic signal (strains) in combina-
tion with the distribution of blaNDM variants (mechanism) and
plasmids (vehicle) revealed local and regional patterns of
circulation of carbapenem non-susceptible ST147 within the
Philippines, which could not be identified based solely on the RPs
and MLST information. Furthermore, comparison with global
ST147 genomes indicated that clade IV may be unique to the
Philippines (Supplementary Fig. 6).
International scale of surveillance—high-risk clone of E. coli
ST410 with NDM-1 and OXA-181. Recent reports of E. coli
Table 1 Organisms from the retrospective sequencing survey described in this study.
Organism (code) Key resistance(s) Antibiotics tested by ARSP Genomes Sentinel sites
K. pneumoniae (Kpn) Carbapenems, ESBL-producing AMP, FOX, CAZ, CRO, FEP, IPM, AMC, TZP, GEN, AMK,
CIP, SXT
340 18
E. coli (Eco) Carbapenems, ESBL-producing AMP, FOX, CAZ, CRO, FEP, IPM, AMC, TZP, GEN, AMK,
CIP, SXT
181 17
P. aeruginosa (Pae) Carbapenems CAZ, FEP, IPM, MEM, TZP, GEN, TOB, AMK, CIP 176 17
A. baumannii (Aba) Carbapenems CAZ, CRO, IPM, SAM, TZP, GEN, AMK, CIP, SXT 108 13
Key resistances were used to select the isolates for WGS. The number of draft genomes obtained and the number of ARSP sentinel sites they represent are indicated. Antibiotics tested by ARSRL for
each organism are abbreviated according to their WHONET codes: AMC amoxicillin/clavulanic acid, AMK amikacin, AMP ampicillin, CAZ ceftazidime, CIP ciprofloxacin, CRO ceftriaxone, GEN
gentamicin, FEP cefepime, FOX cefoxitin, IPM imipenem, MEM meropenem, SAM ampicillin/sulbactam, SXT trimethoprim/sulfamethoxazole, TOB tobramycin, TZP piperacillin/tazobactam.
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(Pae), https://microreact.org/project/ARSP_KPN_2013-14 (Kpn) and https://microreact.org/project/ARSP_ECO_2013-14 (Eco).
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ST410 international high-risk clones carrying class D and class B
carbapenemases17,18 are particularly alarming in light of their
wide geographic distribution and the broad variety of niches this
clone can occupy19,20. ST410 was the second most prevalent ST in
the retrospective collection of E. coli (13.2%, N= 24),
encompassing a large proportion of imipenem-resistant isolates
(N= 15), and the three expanding possible-XDR RP-5,6,7 (Sup-
plementary Fig. 9). The phylogenetic tree of 24 ST410 genomes
showed that isolates with the possible-XDR profiles clustered
within one clade (Fig. 6a), which can be further delineated by the
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distribution of carbapenemase genes and variants into three dif-
ferent clones carrying blaNDM-4 (N= 1), blaNDM-1 (N= 8) or both
blaNDM-1 and blaOXA-181 (N= 5). The phylogenetic analysis with
global E. coli ST410 genomes confirmed that these are indepen-
dent clones, as they were found interspersed with international
genomes within a major high-risk lineage (Fig. 6b and Supple-
mentary Note 5).
K. pneumoniae carrying blaNDM-1 and blaOXA-181 have been
previously reported21,22, as well as E. coli ST410 harbouring
blaNDM-5 and blaOXA-181 from Egypt23, Denmark and the UK18,
but, to our knowledge, this is the first report of E. coli carrying
both blaNDM-1 and blaOXA-181, which is likely to have dissemi-
nated between two sentinel sites (NMC and VSM). We identified
five plasmids in the representative strain 14ARS_NMC0074
(Table 4 and Supplementary Fig. 10). The IncX3 plasmid carrying
blaOXA-181 (p14ARS_NMC0074-5) was identical to plasmid
pAMA1167-OXA-181 isolated previously from an E. coli
ST410 strain24 (Supplementary Fig. 10). Mapping short reads to
p14ARS_NMC0074-5 showed that this plasmid is the main
vehicle of blaOXA-181 in the Philippines, as in the international
genomes (Fig. 6b18). However, we did not identify any known
plasmids similar to the IncA/C2 plasmid with blaNDM-1
(p14ARS_NMC0074-2), though it shared ~90% of its backbone
with the IncA/C2 plasmid described above from K. pneumoniae
ST147 strain 13ARS_VSM0593 (Supplementary Fig. 10). This
plasmid backbone was found in E. coli ST410 genomes from the
Philippines, but not in international genomes (Fig. 6b).
Altogether, our results show that that the Philippine E. coli
ST410 genomes represent diverse lineages of the global circulating
population, with evidence of frequent international introductions.
These lineages are characterized by a diverse repertoire of
carbapenemase genes and variants, amassed via a combination of
conserved international plasmids and locally circulating plasmids.
Discussion
National networks of laboratory-based surveillance are a key
pillar within the Global Action Plan to combat AMR, with the
reference laboratory playing a central role in the dissemination of
surveillance data to local, national and international stakeholders.
The Philippines ARSP surveillance data have shown increasing
resistance trends for key bug–drug combinations (Figs. 1b and
2a). In this study, the analysis of the dynamics of RPs showed the
concomitant expansion of specific resistance phenotypes
(Fig. 2b). By complementing laboratory data with WGS and
linking the operational units of laboratory and genomic surveil-
lance, we revealed a diversity of genetic lineages, AMR mechan-
isms and vehicles underlying the expansion of carbapenem
resistance phenotypes (Figs. 1a and 3). The combination of these
three components vastly improved our understanding of the
drivers of carbapenem resistance in the Philippines at different
geographical scales, from an plasmid-driven local outbreak of K.
pneumoniae ST340 (Fig. 4), to the expansion of a K. pneumoniae
ST147 clone carrying NDM-1 in an IncA/C2 plasmid without any
close match in international genomes (Fig. 5), to the independent
introductions of international epidemic clone E. coli ST410 that
can acquire plasmids of local circulation (Fig. 6).
A crucial aspect of AMR surveillance is the detection of the
emergence and spread of high-risk clones. In traditional labora-
tory surveillance, RPs can be analyzed with spatiotemporal
algorithms to detect hospital outbreaks25 or dissemination of
phenotypic subpopulations between hospitals26. Cluster detection
based on RPs depends on consistent and complete antibiograms
within and across sentinel sites. During the course of our project
it became apparent that there were inconsistencies in the panels
of antibiotics tested by the sentinel sites (missing data or different
antibiotics tested), which led to the exclusion of samples from the
analysis of the dynamics of RPs (Fig. 2). These inconsistencies
would also hamper cluster detection based on RPs, or the early
detection of novel emerging RPs that could act as indicators of
novel high-risk clones. The joint discussions of these observations
by the two collaborating teams led to an effort to reinforce the
standardization of antibiotic testing across the ARSP sentinel
sites, which was coordinated by the ARSRL.
Even with complete and comprehensive susceptibility testing,
RPs can only provide a coarse view of the spread of AMR, and
sometimes lead to clusters of disparate genetic relatedness (Fig. 3
and Supplementary Fig. 2). Integration of WGS into laboratory-
based AMR surveillance can substantially improve the detection
of high-risk clones by providing a high-resolution picture of
genetic lineages (strains), AMR mechanisms (genes/mutations)
and vehicles (MGEs, Fig. 1a). We identified high-risk clones
within known international epidemic clones at the local, national
and international scales by linking clonal relatedness, geographic
clustering, epidemiological data and gene and plasmid content
with interactive web tools27.
At the local scale, we identified a plasmid-driven NICU outbreak
of carbapenem-resistant K. pneumoniae. The epidemiological data
captured in WHONET was key to support the interpretation of the
genomic findings, triggering a retrospective investigation. This
previously undetected outbreak was traced to an IncFII plasmid
carrying blaNDM-1 in the genetic context of ST340 (Fig. 4a). Yet, the
endemic IncFII plasmid was found across multiple wards, and
genetic backgrounds (STs, Fig. 4b), indicating a major role in the
burden of carbapenem resistance K. pneumoniae in this hospital. A
second IncFIB-IncFII plasmid found only within the ST340 lineage
might have contributed to the persistence and transmission of this
clone in the NICU, by carrying several genomic islands with a role
in survival in the host and in the environment (Supplementary
Fig. 5). ST340 is a member of the drug-resistant clonal complex
258 and has been reported to cause outbreaks worldwide28. Our
findings were disseminated to the local stakeholders (i.e., hospital)
via a forum with NICU staff, paediatricians and ARSRL repre-
sentatives. Infection control strategies were implemented, which
ultimately bolstered the infection control team of this hospital.
Control of healthcare-associated infections is crucial to containing
Table 2 Plasmids from K. pneumoniae ST340 strain 13ARS_MMH0112.
Plasmid Size (bp) Replicons AMR genes Match accession (size) Accession
p13ARS_MMH0112-2 243,650 IncFIB(K), IncFII(K) blaCTX-M-15, blaTEM-1B, blaOXA-1, aac(3)-IIa, aac(6′)-Ib-cr,
aph(6)-Id, aph(3″)-Ib, aph(3′)-Ia, aac(6′)-Ib-cr, qnrB1,
mph(A), sul2, tet(A)
NA LR697123
p13ARS_MMH0112-3 101,540 IncFII(Yp) blaNDM-1, rmtC, sul1 MG462729.1
(110,787 bp)
LR697124
The replicons and AMR genes were identified with the PlasmidFinder and ResFinder databases, respectively. The match accession indicates the accession code when at least one match of more than 90%
query sequence coverage and 99% identity was found in the NCBI nucleotide database.
NA not available.
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the spread of AMR29. The roadmap from sequence data to
actionable data for infection control and prevention within a
hospital has been mapped by multiple use cases30,31 and supported
by recent studies on implementation and cost-effectiveness in
high-resource settings32,33. This study makes a case for extending
this roadmap to LMICs that have infection control capacity
in place.
At the national scale, the combined information on strain,
carbapenemase gene/variant and vehicle shows a granular picture
of carbapenem-resistant K. pneumoniae ST147 that uncovers the
geographic distribution of high-risk clones. ST147 is an interna-
tional epidemic clone that causes carbapenem-resistant infections
mediated by NDM, OXA-48-like and VIM carbapenemases28,34.
Notably, ST147 was not reported in a recent study of K. pneu-
moniae from seven healthcare facilities across South and South
East Asia35, which did not include the Philippines. Within the
seemingly well-established genetic background of clade IV
(Fig. 5), a high-risk clone characterized by the presence of
blaNDM-1 within plasmid p14ARS_VSM0843-1 displayed local
clonal expansion in one sentinel site, while another high-risk
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clone characterized by the presence of blaNDM-1 within plasmid
p13ARS_GMH0099 had also disseminated geographically across
five different sites (Fig. 5). Clonal expansion followed by geo-
graphical dissemination is usually attributed to the acquisition of
an AMR determinant36. The extent of the geographical dis-
semination of the different high-risk clones could be attributed to
the different plasmid backbones (vehicle), but differences in the
genetic background (strain) could also be at play. The presence of
a robust AMR surveillance network such as the ARSP is key for
the detection of geographical dissemination of high-risk clones at
a regional/national level, and for the dissemination of the infor-
mation to national stakeholders. In this respect, the ARSRL is
currently evaluating formats for the inclusion of genomic data
into their annual surveillance reports. The reference laboratory
directors can also alert hospitals across the country to establish
concerted infection control measures, as well as relay this infor-
mation to the national DOH for the formulation of evidence-
based guidelines.
At the global scale, we identified several high-risk clones of E.
coli ST410 circulating the in the Philippines, with the evidence of
frequent international transmission, in agreement with a previous
report18. Previous reports of carbapenem-resistant E. coli ST410
from the Western Pacific and South East Asia regions described
the presence of blaOXA-181 in China17,37, blaNDM-1 in Singapore38,
blaNDM-5 in South Korea39, or the combination of blaNDM-5 and
blaOXA-181 in Myanmar40 and South Korea39. The repertoire of
carbapenemases in the retrospective collection of ST410 from the
Philippines seemed to be in tune with the genes/variants circu-
lating locally, as most isolates carried the prevalent variant
blaNDM-1. Of note was the high-risk clone carrying both blaNDM-1
and blaOXA-181, a combination hitherto unreported in E. coli
ST410, and acquired through the combination of a plasmid of
local circulation and a conserved international plasmid, respec-
tively. This suggests that E. coli ST410, a successful pandemic
lineage, can not only easily disseminate, but it can also adjust the
complement of carbapenemases by acquiring endemic plasmids
along the way. Global AMR surveillance networks, such as the
WHO GLASS8, are paramount to detect the emergence and
monitor the spread of resistance at the international level and
inform the implementation of targeted prevention and control
programmes. The ARSRL has been supplying laboratory surveil-
lance data to GLASS since 2015, and presented their experience
with WGS at a WHO technical consultation on the application of
WGS for national, regional and global surveillance in 2020, thus
becoming an international contributor in both fields.
Collecting information on AMR that can be rapidly trans-
formed into action requires harmonized standards, especially at
the national and international levels8. For laboratory data,
WHONET serves this purpose in the ARSP and in over 2000
clinical, public health, veterinary and food laboratories in over
120 countries worldwide26, while GLASS serves this purpose at
the global level. Genomic data are amenable to standardization29,
and national public health agencies41 and international surveil-
lance networks42 are adopting diverse schema to identify and
name genetic lineages. However, a global standard system for
defining a cluster has not been implemented beyond the level of
discrimination of MLST. Likewise, different databases of AMR
mechanisms43–45 may differ in content and nomenclature. Thus,
the standardization of genomic data, as well as the provision of
platforms, for the uptake of genomic information is crucially
moving forward, and for ongoing AMR surveillance.
Containment of AMR at a global level requires an international
concerted effort. High-risk clones have the propensity to dis-
seminate rapidly, and genomics can improve the detection of
their emergence and spread. This highlights the increasing need
to build equitable partnerships to facilitate ownership transfer of
genomic epidemiology capacity (operational, analytical and
interpretational) to enhance national AMR surveillance pro-
grammes within low-resource settings. The binational partner-
ship of this project led to a large retrospective survey of bacterial
pathogens that has provided the first in-depth genomic view of
the AMR landscape in the Philippines and established contextual
data for ongoing local prospective sequencing. In parallel,
through training and transfer of expertize in laboratory proce-
dures and bioinformatics, the open exchange of data, and col-
lective interpretation of results, we have expanded the existing
capacity of a national reference laboratory with WGS focused on
action for public health. WGS commenced at the ARSRL in 2018
with the Illumina MiSeq equipment available locally. A new
dedicated bioinformatics server was installed at ARSRL for
sequence data storage and analysis. Collective data interpretation
was aided by data sharing via interactive web tools such as
Microreact (www.microreact.org)27 and Pathogenwatch (www.
pathogen.watch) to leverage the expertize from both CGPS and
ARSRL. The results of the retrospective survey were presented to
the representatives of the sentinel sites during the ARSP annual
meetings and at international conferences, at first by the members
of CGPS, followed by presentations by the members of the
ARSRL in subsequent years46,47. The ARSRL staff conducted its
first outbreak investigation using WGS in July 2019, with
Table 3 Plasmids carrying NDM genes in K. pneumoniae ST147 representative isolates.
Plasmid Size (bp) Replicons AMR genes Match
accession (size)
Accession
p14ARS_CVM0040-2 110,787 IncFII(Yp) blaNDM-1, rmtC, sul1 MG462729.1
(110,787 bp)
LR697128
p13ARS_GMH0099 273,158 IncA/C2, IncR,
IncFIA(HI1)
blaNDM-1, blaCTX-M-15, blaOXA-1, blaOXA-10, blaTEM-1B, aph
(3’)-VI, aph(3′)-Ia, aadA1(x2), aac(6′)-Ib-cr, aph(6)-Id,
strA, strB, qnrS1, mph(A), erm(42), ere(A), floR, cmlA1
(x2), arr-2 (x2), sul1(x3), sul2, dfrA14
NA LR697099
p13ARS_VSM0593-1 181,414 IncA/C2 blaNDM-1, aph(3′)-Ia, mph(A), cmlA1, floR, sul1, sul2, qnrS1,
arr-3,
NA LR697125.1
p14ARS_MMH0055-5 44,885 IncX3 blaNDM-7 KP776609.1
(45,122 bp)
LR697126
p14ARS_VSM0843-1 95,284 IncR, IncFIA(HI1) blaNDM-1, blaCTX-M-15, blaTEM-1B, aph(3’)-VI, aph(6)-Id,
aph(3″)-Ib, aph(3’)-VI, aadA1, cmlA1, sul1, sul2, arr-3
NA LR697132
The replicons and AMR genes were identified with the PlasmidFinder and ResFinder databases, respectively. The match accession indicates the accession code when at least one match of more than
90% query sequence coverage and 99% identity was found in the NCBI nucleotide database.
NA not available.
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sequencing, bioinformatics, and reporting to the DOH conducted
locally, with a turnaround time of 8 days from sample receipt to
report preparation.
While progress has been made, significant challenges remain to
bring genomics into routine surveillance in low-resource settings.
These include, but are not limited to, challenges in the supply
chain and procurement of WGS reagents and equipment, vastly
differing costs between high- and low-income settings, shortage
of skilled local bioinformaticians due to both limited access to
training and difficulties in staff retention, and the lack of plat-
forms to feedback the actionable genomic data to sentinel sites. In
addition, it was expected that the timeline from implementation
of a disruptive technology such as WGS to full adoption by all the
relevant stakeholders was to exceed the period of one academi-
cally funded project. The continued collaboration with the
ARSRL (via an NIHR-funded project) is building on the foun-
dations laid by this study to tackle some of the challenges men-
tioned above, and to improve on the translation of genomic data
into public-health action and policy. We laid the foundations for
the sustainable implementation of WGS and genomic epide-
miology within national surveillance networks in LMICs, which
can be extended to other locations to tackle the global challenge
of AMR.
Methods
Ethics statement. Ethical approval is not applicable as per the Research Institute
for Tropical Medicine—Institutional Review Board. This study uses archived
bacterial samples processed by ARSP. No identifiable data were used in this study.
ARSP workflow and data. The ARSP implements AMR surveillance on aerobic
bacteria from clinical specimens. The programme collects culture and anti-
microbial susceptibility data from its 24 sentinel sites and 2 gonorrhoeae surveil-
lance sites. The sentinel sites participate in an external quality assessment scheme
conducted by the reference laboratory to ensure quality of laboratory results. Case
finding is based on priority specimens sent routinely to the hospitals’ laboratories
for clinical purposes, and is thus based on the diagnostic practices of the clinicians,
as well as the resources available to the patient to cover the culture and suscept-
ibility testing. Sentinel sites submit monthly results of all culture and susceptibility
tests to the ARSRL via WHONET, a free Windows-based database software for the
management and analysis of microbiology laboratory data with a special focus on
the analysis of antimicrobial susceptibility test results6. Multi-drug-resistant phe-
notypes are classified according to recommended standard definitions48. Select
isolates are referred to the ARSRL for confirmatory testing if they fall in one of the
three following categories: (1) organisms of public health importance regardless of
their resistance phenotype, such as Salmonella enterica ser. Typhi, Streptococcus
pneumoniae and Vibrio cholerae; (2) organisms with emerging resistance, such as
carbapenem resistance; (3) organisms with rare susceptibility patterns, such as
vancomycin-resistant Staphylococcus aureus or ceftriaxone-resistant Neisseria
gonorrhoeae. At the ARSRL, all referred isolates are re-identified using standardized
culture, and susceptibility tested by disc diffusion or minimum inhibitory con-
centration (MIC) determined using the most current guidance for antibiotic test
panels and breakpoints recommended by the Clinical and Laboratory Standards
Institute. Serotyping for S. pneumoniae, H. influenzae, Salmonellae and V. cholerae
is conducted to further characterize the isolates.
ARSP data and bacterial isolates included in this study. Phenotypic data col-
lected since 1988 from antimicrobial susceptibility tests were summarized with
WHONET v5.6 to compute yearly resistance rates for key pathogen–antibiotic
combinations. Only the first bacterial isolate per patient per species per year was
included in the calculations.
RPs derived from the antibiograms were summarized per organism with
WHONET v5.66, and their relative abundance visualized with Tableau Desktop.
Data collected between 2009 and 2017 were included in the analysis as the number
of sentinel sites collecting data remained relatively stable during this period
(22–24 sites). Isolates with missing data for any antibiotic on the panels listed on
Table 1 were excluded.
The bacterial pathogens included in the See and Sequence study were those
responsible for the majority of antimicrobial-resistant infections in the Philippines.
These included carbapenemase-producing Pseudomonas aeruginosa and
Acinetobacter baumanii, carbapenemase-producing and ESBL-suspect Escherichia
coli and Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus,
Neisseria gonorrhoeae, non-typhoidal Salmonella, and Salmonella enterica ser.
Typhi. Linked epidemiological data included location and date of specimen
collection, type of specimen, type of patient (in or outpatient) and sex and age of
the patient. We utilized a proxy definition for infection origin whereby patient first
isolates collected in the community or on either of the first 2 days of hospitalization
were categorized as community infection isolates, while isolates collected on
hospital day 3 or later were categorized as HAI isolates8.
In this article, we focus on carbapenemase-producing organisms. All
carbapenemase-producing K. pneumoniae and E. coli isolates referred to,
confirmed, and banked by the ARSRL in 2013–2014 were selected for the
retrospective sequencing survey. Approximately 100 isolates of carbapenemase-
producing P. aeruginosa and A. baumannii each were selected according to the
following criteria: (1) referred to ARSRL in 2013–2014; (2) complete RP (i.e., no
missing data); (3) overall prevalence of the RP in the ARSP data (including both
referred and non-referred isolates); (4) geographical representation of different
sentinel sites. The number of isolates included from each sentinel site was
proportional to their relative abundance and estimated from (n/N) × 100 (rounded
up), where n is the total number of isolates from one site, and N is grand total of
isolates; (5) when both invasive and non-invasive isolates representing a
combination of RP, sentinel site and year of collection were available, invasive
isolates (i.e., from blood, or cerebrospinal, joint, pleural and pericardial fluids) were
given priority. In addition, ~100 isolates of ESBL-producing E. coli and K.
pneumoniae each were included as per the criteria above. Pan-susceptible isolates
were only available for P. aeruginosa isolates and were also included in the
retrospective sequencing survey.
Lyophilisates of the selected bacterial isolates were re-suspended in 0.5 mL of
tryptic soy broth, plated onto MacConkey agar plates and incubated at 35–37 °C
for 18–24 h. The species identity of the revived bacterial isolates was confirmed by
characterization of the colony morphology and conventional biochemical tests
(e.g., oxidase, motility and sugar fermentation using triple sugar iron agar test).
Phenotypic re-testing was performed on the resuscitated isolates based on the
phenotype stored in WHONET. Carbapenemase production in resuscitated isolates
of Enterobacteriaceae was tested with the modified Hodge test, and confirmed
using the imipenem MIC method with imipenem Etest strips (BioMerieux). P.
aeruginosa and A. baumanii were screened for metallo-beta-lactamase production
using the EDTA synergy test between imipenem disk (10 µg) and EDTA (750 µg/
mL), which was confirmed by imipenem/imipenem inhibitor Etest strips. E. coli
and K. pneumoniae isolates were screened for ESBL with the double-disk synergy
test between aztreonam (30 µg) and amoxicillin/clavulanic acid (20/10 µg) and
confirmed by using the gradient diffusion method with cefotaxime/cefotaxime with
clavulanic acid or ceftazidime/ceftazidime with clavulanic acid Etest strips.
Whole-genome sequencing, assembly and annotation. A. baumanni, E. coli, K.
pneumoniae and P. aeruginosa bacterial strains were shipped to the Wellcome
Sanger Institute streaked onto Nutrient Agar butts contained in screw-cap cryo-
vials, where DNA was extracted from a single colony of each isolate with the
Table 4 Plasmid repertoire of carbapenem-resistant E. coli strain 14ARS_NMC0074.
Plasmid Size (bp) Replicons AMR genes Match accession (size) Accession
p14ARS_NMC0074-2 146,817 IncA/C2 blaNDM-1, blaOXA-10, aadA1, aph(3’)-VI, aph(3′)-Ia, mph(A),
cmlA1, floR, sul1, sul2, dfrA14, qnrS1, arr-2
NA LR697127
p14ARS_NMC0074-5 51,479 IncX3 blaOXA-181, qnrS1 CP024806.1 (51,479 bp) LR697131
p14ARS_NMC0074-4 81,712 IncFII/IncFIA blaCTX-M-15, blaTEM-1B, blaOXA-1, aadA5, aac(6′)-Ib-cr, sul1,
tet(B), dfrA17
CP024805.1 (111,310 bp) LR697131
p14ARS_NMC0074-3 82,418 IncFII blaTEM-1, mph(A), erm(B) NA LR697130
p14ARS_NMC0074-6 2088 Col(BS512) – CP024803.1 (2088 bp) LR697133
The replicons and AMR genes were identified with the PlasmidFinder and ResFinder databases, respectively. The match accession indicates the accession code when at least one match of more than
90% query sequence coverage and 99% identity was found in the NCBI nucleotide database.
NA not available.
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QIAamp 96 DNA QIAcube HT kit and a QIAcube HT (Qiagen; Hilden, Germany).
DNA extracts were multiplexed and sequenced on the Illumina HiSeq platform
(Illumina, CA, USA) with 100-bp paired-end reads.
The quality of the sequence data was assessed for median base quality >30,
mapping coverage >80% of the length of a reference genome sequence of the same
species (A. baumannii ATCC 17978, E. coli UPEC_ST131, K. pneumoniae subsp.
pneumoniae Ecl8 and P. aeruginosa LESB58), and >80% of the sequence reads
assigned to the corresponding species with Kraken v0.10.6-a2d113dc8f49 and a
reference a database of all viruses, archaea and bacteria genomes in RefSeq50 and
the mouse and human reference.
Annotated assemblies were produced using the pipeline described in51. For each
sample, sequence reads were used to create multiple assemblies using
VelvetOptimiser v2.2.552 and Velvet v1.253. An assembly improvement step was
applied to the assembly with the best N50 and contigs were scaffolded using
SSPACE v2.054 and sequence gaps were filled using GapFiller v1.1155. Automated
annotation was performed using PROKKA v1.556 and a genus-specific database
from RefSeq50. The quality of the assemblies was assessed for total size, number of
contigs, N50 and GC content appropriate for each species, with all genomes passing
quality control characterized by assemblies of <150 contigs and N50 > 60,000.
Phylogenetic analysis. Evolutionary relationships between isolates were inferred
from SNPs by mapping the paired-end reads to the reference genomes of A.
baumannii A1 (CP010781), E. coli EC958 (HG941718), K. pneumoniae subsp.
pneumoniae (AP006725) or P. aeruginosa LESB58 (FM209186), using the Burrows
Wheeler aligner v0.7.1257 to produce a BAM file. PCR duplicate reads were
identified using Picard v1.9258 and flagged as duplicates in the BAM file.
Variation detection was performed using samtools mpileup v0.1.1959 with
parameters -d 1000 -DSugBf and bcftools v0.1.1960 to produce a BCF file of all
variant sites. The option to call genotypes at variant sites was passed to the bcftools
call. All bases were filtered to remove those with uncertainty in the base call. The
bcftools variant quality score was required to be >50 (quality < 50) and mapping
quality >30 (map_quality < 30). If not all reads gave the same base call, the allele
frequency, as calculated by bcftools, was required to be either 0 for bases called the
same as the reference, or 1 for bases called as an SNP (af1 < 0.95). The majority
base call was required to be present in at least 75% of reads mapping at the base
(ratio < 0.75), and the minimum mapping depth required was 4 reads, at least two
of which had to map to each strand (depth < 4, depth_strand < 2). Finally,
strand_bias was required to be <0.001, map_bias < 0.001 and tail_bias < 0.001. If
any of these filters were not met, the base was called as uncertain.
A pseudogenome was constructed by substituting the base call at each site
(variant and non-variant) in the BCF file into the reference genome, and any site
called as uncertain was substituted with an N. Insertions with respect to the
reference genome were ignored and deletions with respect to the reference genome
were filled with Ns in the pseudogenome to keep it aligned and the same length as
the reference genome used for read mapping. For sequence-type-specific
phylogenies, MGEs and recombination regions detected with Gubbins v1.4.1061
were masked from the alignment of pseudogenomes produced by mapping against
the genomes of K. pneumoniae strain CAV1217 (ST340, CP018676.1), K.
pneumoniae strain MS6671 (ST147, LN824133.1) or E. coli strain AMA1167
(ST410, CP024801.1). Alignments of only variant positions were inferred with snp-
sites v2.4.162 and were also used to compute pairwise SNP differences between
isolates (https://github.com/simonrharris/pairwise_difference_count).
Maximum-likelihood phylogenetic trees were generated with RAxML v8.2.863
based on the generalized time reversible model with GAMMA method of
correction for among-site rate variation and 100 bootstrap replications. Trees were
midpoint rooted.
The phylogenetic trees, genomic predictions of AMR and genotyping results
were visualized together with the ARSP epidemiological data using Microreact27.
In silico predictions of AMR determinants and plasmid replicons. Known
antibiotic resistance determinants were identified using Antibiotic Resistance
Identification By Assembly v.2.6.1 (ARIBA)64. For acquired genes an in-house
curated database comprising 2316 known resistance gene variants was used
(https://figshare.com/s/94437a301288969109c2)65. Full-length assembled matches
with identity >90% and coverage >5× were considered as evidence of the presence
of the gene in the query genome. Further manual inspection of the results excluded
13 matches that passed the above filters but that were suspected low-level con-
tamination. Mutations in ompK35 and ompK36 genes were detected with ARIBA
and the Comprehensive Antimicrobial Resistance Database44 and the output was
inspected for truncations, interruptions and frameshifts.
Plasmid replicons were identified with ARIBA and the PlasmidFinder
database66. Full-length assembled matches with 100% identity were considered as
evidence of the presence of the replicon gene.
In silico multi-locus sequence typing. Multi-locus STs were determined from
assemblies with MLSTcheck v1.00700167 or from sequence reads with ARIBA64,
using species-specific databases hosted at PubMLST (https://pubmlst.org)68 for E.
coli69, A. baumannii70, P. aeruginosa71 or at BIGSdb (https://bigsdb.readthedocs.io/
en/latest/#)68 for K. pneumoniae72.
MLST calls from P. aeruginosa genome sequences were manually curated as we
noted the presence of two genes exhibiting 100% sequence identity to different acsA
alleles in the pubmlst database (accessed April 2019), which confounded the in silico
predictions. This was not privy to the genomes is this study, since the genome
sequence of reference strain NCGM2_S1 (accession AP012280), known to belong to
ST235, showed two genes with locus tags NCGM2_1665 (nt position
1808730–1810685) and NCGM2_0806 (nt positions c879796-881733) that are
annotated as acsA and acsB, respectively, and are 100% identical to alleles acsA_38
and acsA_225, respectively (https://pubmlst.org/data/alleles/paeruginosa/acsA.tfa,
accessed Apr 2019). Furthermore, the same was only observed for the acsA allele both
from assemblies (MLST_check) and raw reads (ARIBA-MLST), and therefore
unlikely the result of contamination with other strains. Allele acsA_38 defines ST235,
but allele acsA_225 defines a novel ST. Thus, when two different acsA alleles were
detected in a P. aeruginosa genome we selected the one associated with a known ST.
Characterization of carbapenemase plasmids. Select K. pneumoniae
(14ARS_CVM0040, 14ARS_MMH0055, 13ARS_GMH0099, 14ARS_VSM0843,
13ARS-VSM0593 and 13ARS_MMH0112) and E. coli (14ARS_NMC0074) isolates
were also sequenced with PacBio RS II or Sequel (Pacific Biosciences, CA, USA) or
Oxford Nanopore Gridion (Oxford Nanopore, Oxford, UK) platforms. Hybrid
assemblies from short and long reads were obtained with Unicycler v0.4.073 with
default parameters, except for 13ARS_GMH0099 for which the bold assembly
mode was used. The sequence of the p13ARS_GMH0099 plasmid was manually
curated with Bandage v0.8.174 circularized with Circlator v1.5.375, and further
polished with Quiver (Pacific Biosciences, CA, USA).
The presence of AMR genes and plasmid replicons in the plasmid sequences
was detected with ResFinder45 and PlasmidFinder66, respectively. Matches with
identity larger than 98% were reported. Detailed annotations of plasmids were
obtained with MARA76. Visual comparisons between plasmid sequences were
created with BRIG v1.077 with default BLAST v2.7.0 parameters.
The distribution of plasmids across draft genomes was inferred by mapping
short reads to the plasmid sequences with smalt v0.7.4 with identity threshold y=
96% and random alignment of reads with multiple mapping positions of equal
score (-r 1). The BAM file was sorted and indexed with samtools
v0.1.19–44428cd59, which was also used to and generate a pileup (mpileup
-DSugBf) of the alignment records in BCF format. A pseudo-plasmid sequence in
fastq format was constructed with the bcftools view and vcfutils.pl vcf2fq
programmes, and the sequence length coverage (%) of the reference plasmid was
computed.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Raw sequence data generated during this study have been deposited in the European
Nucleotide Archive (ENA) under the study accession PRJEB17615. Run accessions are
provided in the Microreact projects linked throughout the paper and below. The plasmid
sequence assemblies generated during this study are available from Tables 2–4. The
resistance database used in this study is available at: https://figshare.com/s/
94437a301288969109c2. The multi-locus sequence-type databases used in this study are
available at PubMLST (https://pubmlst.org) or at BIGSdb (https://bigsdb.readthedocs.io/
en/latest/#).
The data presented in this study are available from the following Microreact projects:
https://microreact.org/project/ARSP_ABA_2013-14
https://microreact.org/project/ARSP_PAE_2013-14 https://microreact.org/project/
ARSP_KPN_2013-14 https://microreact.org/project/ARSP_ECO_2013-14
https://microreact.org/project/ARSP_KPN_ST340_2013-14
https://microreact.org/project/ARSP_KPN_ST147_2013-14
https://microreact.org/project/ARSP_KPN_ST147_GLOBAL
https://microreact.org/project/ARSP_ECO_ST410 https://microreact.org/project/
ARSP_ECO_ST410_GLOBAL
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